Quoin Pharmaceuticals, Ltd. Sponsored ADR QNRX
6.43
0.05
0.78%
as of 25 Sep
- Market cap
- $12.8M
- P/E
- 0.0×
Follow QNRX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.04 | 3.61 | 2.87 | 1.76 |
Net Debt/EBITDA |
1.35 | 4.17 | 2.75 | 1.98 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.56 | 1.16 | 0.97 | 0.59 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.06 | 0.02 | 0.02 | 0.03 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(3.78) | (4.71) | (1.72) | (1.11) | |
Cash per Share |
9.20 | 17.55 | 4.96 | 3.81 | |
Shareholders Equity per Share |
(2.06) | 12.28 | 3.10 | 1.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.06) | 12.28 | 3.10 | 1.39 | |
Free Cash Flow |
(2.23) | (5.03) | (4.87) | (3.14) | |
Working Capital |
0.25 | 14.46 | 9.99 | 5.02 | |
Net Current Asset Value |
(1.62) | 12.74 | 8.41 | 3.60 | |
| Other line items | |||||
Quick Ratio |
0.94 | 3.38 | 2.63 | 1.63 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.78) | (4.71) | (1.72) | (1.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.04 | 1.08 | 1.21 | 1.99 | |
Average Assets |
8.91 | 18.05 | 14.32 | 10.44 | |
Average Common Equity |
2.11 | 11.16 | 7.35 | 3.24 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates